Editorial Note - (2020) Volume 2, Issue 1
I am happy to publicize that the European journal of clinical oncology (EJCO) is a new journal and that gave me opportunity to bring forward the achievements of the journal in the year 2019. As we know EJCO is the newly coined journal, it is under evolution for indexing by different indexing agencies. EJCO has published all the issue at the given period of time and preprint were also published and dispatched within 30 days of the publication of the article online. EJCO accepts all type of manuscripts such as research papers, case reports, review articles, short commentary, mini review etc. EJCO have published two research articles, one case report, one mini review and one commentary in issue 1 of volume 1 and also released issue 2 of volume 1of the year of 2019 there is announcement about Conference and Awards which is going to happen in the year of 2020.
Cancer modus a major challenge to development and it weaken socio-economic advances throughout the world. It is estimated that the number of patients with cancer would increase from 12 million in the year 2008 to 22 million by 2030. The European Journal of Clinical Oncology is strategically positioned in the clinical research setting at this time to help combat the danger of cancer by helping to create innovative therapeutic approaches and offering fresh insights into the mechanisms underlying this complex disease.
European journal of clinical oncology is an open access journal, which is freely accessible to one and all in throughout this world. This journal does not take any kind of charges to their reader and give full access of article to the readers. The scope of the journal encompasses topic Cancer Biology, Prostate Cancer, Colorectal Cancer, Cancer immune therapy, chemotherapy, Cancer pathology.
All the 5 articles submitted to this journal gone through a peer review process some of them are subjected to revision and remaining papers get approved for further processing and published. The time taken for the publishing of an article is very less the article gets published within 7 days after acceptance by the editors. The additional quality of this journal is that the editors are final decision maker about any article publishing. Review process and peer review process completed within given time. If any manuscript does not get accepted in peer review process the author given another chance to improve the manuscript. Journal uses online broadcast and different social media platforms like twitter, Linked In, Facebook for recent updates about what going on in journal to make people aware about the trending topics related to oncology. I would like to acknowledge the contribution of all editors, reviewers, and the other supporting peoples during the final editing of the published articles and the help provided by the editorial assistant in bringing out EJCO issue on time. I am very thankful to them for giving me this opportunity to appreciate the work and other peoples from making this journal successful.
Received: 28-Mar-2020 Published: 23-Apr-2020
Copyright: © 2020 Ravi Kaushik. This is an open access paper distributed under the Creative Commons Attribution License. European Journal of Clinical Oncology is published by Lexis Publisher.
